BBC Collaborating With Cytiva For Providing Training Programs
Aiding Indian biopharma ecosystem through homegrown talent pool
Bangalore Bioinnovation Centre collaborates with Cytiva to provide bioprocessing
training programs for supporting the start-up ecosystem, academia, new ventures,
and biopharmaceutical projects.
February 16, 2022
Bangalore Bioinnovation Centre (BBC), a bio-incubation centre for startups in the field of
Life Sciences (Pharma, Biopharma, MedTech, Agriculture, Food & Nutrition, Industrial
Biotechnology, Environmental Biotechnology) set up under the aegis of KITS (Karnataka
Innovation Technology Society), Department of Electronics, IT, BT and S&T, Government of Karnataka with a liberal funding support from Department of Biotechnology (DBT) Government of India, and Cytiva, a global life science leader, agree to work together to support the start-up ecosystem and academia in the field on biopharmaceuticals by providing a platform for skill development and industry oriented training in the field of bioprocessing (upstream, downstream and analytical characterization).
As per the Invest India’s survey, Indian biotechnology industry estimated to reach 150 billion dollars by 2025, expects to see the number of startups to grow from above 4000 to 10,000 by 2024. The Bangalore Bioinnovation Centre is a world class incubation
Centre with Central
of 60,000 square feet and is engaged in providing infrastructure support, skill development and assistance to start-up companies, ventures, and projects in biopharmaceutical field to help conversion of innovative ideas and research into commercialization. This collaboration aligns well in giving impetus to the innovation ecosystem by driving industry academia linkages and eventually, enhanced translational research.
Dr Jitendra, Managing Director, Bangalore Bioinnovation Centre says: “This partnership
will help to create a training program catering to the Biopharma Industry which is much
needed today”.
Vaggu Raghavendra Goud, General Manager of Cytiva South Asia, says: “Cytiva has been supporting the Indian biotechnology industry for more than 30 years. With the industry experiencing fast growth, the need of skilled talents is increasing. This collaboration enables us to bring our global knowledge and expertise to support BBC, local biotech companies and academia in fulfilling the need for skilled talent which will lead to improved efficiency, reduced time and cost of regional biopharma industry development.”
Talent is critical for all industries, but it is particularly critical for the biopharma industry
given the complexity of the sector. According to Cytiva Biopharma Resilience Index,
talent pool is the weakest link in the global biopharma industry. 65% of Indian respondents in the Biopharma Resilience Index say that sourcing talent in technology, manufacturing, and R&D is a substantial challenge. Thus, the demand for the collaboration is expected to be high.
About Cytiva
Cytiva is a global life sciences leader with more than 8,000 associates across 40
countries dedicated to advancing and accelerating therapeutics. As a trusted partner to
customers that range in scale and scope, Cytiva brings speed, efficiency and capacity to
research and manufacturing workflows, enabling the development, manufacture and
delivery of transformative medicines to patients.
Media Contact –
Zhao Meng
[email protected]
